Ogier advise on largest scheme to come before Royal Court

Monday 14 January 2019

Ogier has advised one of the world's largest pharmaceutical firms on a £46billion acquisition of Shire, creating one of the world's largest pharmaceutical firms.

Partners Simon Dinning (Global Head of Corporate) and Nick Williams (Head of Dispute Resolution in Jersey) led the team, which advised Japan's Takeda Pharmaceutical. Senior Associate James Angus assisted.

The firm, which advised on the Jersey aspects of the deal, say that the deal is the largest ever foreign takeover by a Japanese company.

Their work, which involved working alongside lead bidder counsel Linklaters, resulted in a scheme that became effective on 8 January. It was passed through the Jersey's Royal Court, and is believed to be the highest value scheme to have come before it.

Mr Dinning said the firm was "delighted" to have acted for Takeda alongside Linklaters on what he described as a "very significant transaction".

Mourant were also involved in the deal, advising Shire, a client they have advised for over 10 years.

Pictured: Mourant Partner, Robert Hickling.

The firm's team was led by Robert Hickling, who was supported by Stephen Alexander, Paul Martin, Jon Woolrich, Amy Wilson, Rachel Needham, Carla Benest and Katie Philipps.

The team managed the scheme process and acted as Jersey counsel alongside lead counsel Slaughter and May on the transaction.